- title: Inhibition of MEK1/2 Forestalls the Onset of Acquired Resistance to Entrectinib in Multiple Models of NTRK1-Driven Cancer
  description: "Created new models of kinase-fusion driven lung cancer and studied their response to MAPKI"
  university: Cell Reports
  number: Fall 2020
  url: https://www.cell.com/cell-reports/fulltext/S2211-1247(20)30979-7
  authors: Vaishnavi A, Scherzer MT, Kinsey CG, Parkman GL, Truong A, Ghazi P, Schuman S, Battistone B, Garrido-Laguna I, McMahon M.
  logo: logos/cell_reports_2020.JPG
  semester:
  - name: Volume 32,Issue 5
    url: https://www.cell.com/cell-reports/fulltext/S2211-1247(20)30979-7
    

- title: Chloroquine Sensitizes GNAQ/11-mutated Melanoma to MEK1/2 Inhibition
  description: "Studied the resistance mechanisms of uveal melanoma cells to the combination of MAPK- and autophaghy- inhibition"
  university:  Clinical Cancer Research
  number: Winter 2020
  url: https://aacrjournals.org/clincancerres/article/26/23/6374/82893/Chloroquine-Sensitizes-GNAQ-11-mutated-Melanoma-to
  authors: Vaishnavi A, Juan J, Jacob M, Stehn C, Gardner EE, Scherzer MT, Schuman S, Van Veen JE, Newberg JY, Liu A, Mann K, Adams DJ, Grossmann A, Mann MB, McMahon M.
  logo: logos/ccr_2020.JPG
  semester:
  - name: Volume 26,Issue 23, p6374â€“6386
    url: https://aacrjournals.org/clincancerres/article/26/23/6374/82893/Chloroquine-Sensitizes-GNAQ-11-mutated-Melanoma-to
